汤臣倍健(300146) - 2025年12月9日投资者关系活动记录表
By-healthBy-health(SZ:300146)2025-12-09 10:22

Group 1: Product Development and Market Strategy - The company plans to innovate product development based on diverse consumer demands and channel characteristics, focusing on core categories [2] - The pharmacy channel's professional service capabilities are irreplaceable, and the company aims to enhance operational capabilities through digital infrastructure and new delivery models [2] - The company will strengthen partnerships with high-potential supermarket chains to explore offline growth opportunities [2] Group 2: Online Sales and Revenue Distribution - Douyin accounts for approximately 20% of online sales, while Tmall and JD.com together account for about 60% [3] - The main brand contributes over 50% of total revenue, with Jianliduo and Lifespace each accounting for over 10% [3] - The company has seen significant repurchase rates for new SKUs launched online, particularly among high-consumption demographics [3] Group 3: Distributor Management and Market Position - The reduction in the number of distributors is attributed to business adjustments and optimization efforts [3] - The company is focused on long-term quality development and enhancing investor returns through stable dividend policies and share buybacks, with cumulative cash dividends exceeding 70% of net profit since listing [3] Group 4: Financial Performance Insights - The company's net profit in the fourth quarter is typically lower due to sales expense timing, bonus accruals, and expense settlements [3] - Ongoing digital strategy projects are aimed at improving sales management and data analysis capabilities, alongside organizational structure optimization for better management quality [3]

By-health-汤臣倍健(300146) - 2025年12月9日投资者关系活动记录表 - Reportify